Newsletter
Newsletter Support JNS

Satellite images show likely military installation in Syria

A military installation near the Lebanese-Syrian border is being utilized to produce precision surface-to-surface missiles, likely with Iranian backing, according to an intelligence report by ImageSat International.

A military installation near the Lebanese-Syrian border that may be producing precision surface-to-surface missiles, likely with Iranian backing, according to an intelligence report published on March 13, 2019, by ImageSat International.
A military installation near the Lebanese-Syrian border that may be producing precision surface-to-surface missiles, likely with Iranian backing, according to an intelligence report published on March 13, 2019, by ImageSat International.

A military installation near the Lebanese-Syrian border is being utilized to produce precision surface-to-surface missiles, likely with Iranian backing, according to an intelligence report published on Wednesday by ImageSat International.

The firm mentioned that neither warheads nor missile engines are being manufactured at the compound in the northwestern Syrian city of Safita, which is almost five miles from the border with Lebanon.

“According to the company, the type of construction, the location of the compound and evidence of activity at the site and its environs increase the probability that at issue is a missile manufacturing plant,” reported Haaretz. “ISI added, however, that there is no way to confirm this assessment due to suspicions that it’s an Iranian site.”

The firm added that there has been increased vehicular activity to the compound in recent months, in addition to a new water tower constructed there.

“The country of Israel joins me in this commitment,” the U.S. president said of the negotiations.
The LAF had claimed five soldiers sustained minor injuries in what it described as an “Israeli enemy attack.”
The Israeli military also killed a Hamas deputy cell commander who doubled as a physician in Shifa Hospital.
Rather than target amyloid plaques, the potential new treatment aims to restore immune functions that naturally decline with age.